ANGELA SANKARAN: Open Payments
NPI 1891064895 · SPOKANE VALLEY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,870 in 98 payments from 16 companies in 2025. Trend: 2023 $2,095 · 2024 $2,292 · 2025 $1,870
Food & beverage: $1,689Education: $181
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $331 |
| Janssen Biotech, Inc. | 19 | $317 |
| Lilly USA, LLC | 10 | $230 |
| Regeneron Healthcare Solutions, Inc. | 5 | $207 |
| UCB, Inc. | 15 | $183 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $148 |
| Amgen Inc. | 5 | $89 |
| Novartis Pharmaceuticals Corporation | 2 | $86 |
| Galderma Laboratories, L.P. | 4 | $84 |
| PFIZER INC. | 2 | $46 |
Products named: TREMFYA, DUPIXENT, EBGLYSS, Bimzelx, SKYRIZI, RINVOQ, OTEZLA, NEMLUVIO.
Industry payments across WA — which companies pay providers there.
